camptothecin has been researched along with Abnormalities, Drug-Induced in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, MK; Han, SS; Kim, JC | 2 |
| Chung, MK; Kim, CY; Kim, JC | 1 |
3 other study(ies) available for camptothecin and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
Effects of CKD-602, a new camptothecin anticancer agent, on pregnant does and embryo-fetal development in rabbits.
Topics: Abnormalities, Drug-Induced; Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Dose-Response Relationship, Drug; Embryo Loss; Female; Fetal Resorption; Injections, Intravenous; Litter Size; No-Observed-Adverse-Effect Level; Pregnancy; Rabbits; Teratogens; Topoisomerase I Inhibitors | 2005 |
Evaluation of the toxic potentials of a new camptothecin anticancer agent CKD-602 on fertility and early embryonic development in rats.
Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Body Weight; Camptothecin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Embryonic Development; Female; Fertility; Injections, Intravenous; Litter Size; Male; No-Observed-Adverse-Effect Level; Organ Size; Rats; Rats, Sprague-Dawley | 2006 |
Reproductive toxicity evaluation of a new camptothecin anticancer agent, CKD-602, in pregnant/lactating female rats and their offspring.
Topics: Abnormalities, Drug-Induced; Animals; Animals, Newborn; Antineoplastic Agents; Behavior, Animal; Body Weight; Camptothecin; Dose-Response Relationship, Drug; Eating; Embryonic Development; Female; Fetal Development; Injections, Intravenous; Lactation; Longevity; Male; Maternal Exposure; No-Observed-Adverse-Effect Level; Pregnancy; Rats; Rats, Sprague-Dawley; Reproduction; Teratogens | 2007 |